INXC-6295

N/A

Report date: 2023/01/05 18:54:33

Base Information

Drug NameINXC-6295
Drug Alias NameINXC-3281
ClassificationOther
Mechanisms of ActionMyc proto-oncogene protein modulators
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInex Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInex Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A